# Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement

Study · id `cardio:ct-nct02779400` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02779400](<https://clinicaltrials.gov/study/NCT02779400>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02779400

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.

## Technical summary

Registry record NCT02779400. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-05-23 (actual); primary completion 2018-04-14 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 220 participants (enrolled count; ClinicalTrials.gov record NCT02779400, source copy `cardio:ctgov-nct02779400-2018-10-15`, retrieved 2026-10-26)
- Started: 2016-05-23 (actual) (ClinicalTrials.gov record NCT02779400, source copy `cardio:ctgov-nct02779400-2018-10-15`, retrieved 2026-10-26)
- Primary completion: 2018-04-14 (actual) (ClinicalTrials.gov record NCT02779400, source copy `cardio:ctgov-nct02779400-2018-10-15`, retrieved 2026-10-26)
- Completion: 2018-06-01 (actual) (ClinicalTrials.gov record NCT02779400, source copy `cardio:ctgov-nct02779400-2018-10-15`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02779400, source copy `cardio:ctgov-nct02779400-2018-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02779400-2018-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement
- Acronym: HEMOPTICS2
- Condition: Healthy
- Condition: Heart Valves
- Condition: Arrhythmias, Cardiac
- Condition: Thromboembolism
- Intervention (Device): Self testing INR device
- Lead sponsor: University Hospital, Grenoble
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: University Hospital, Grenoble (`cardio:org-university-hospital-grenoble`)

## Provenance

Content hash: 620ebaaa090fd7fbed9e79d63a6d3e1f76952777890044aecd447c0561e91211
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
